Click for best price
Antiviral Therapy Market Size, Share 2023
Antiviral therapy is one of the most exciting branches of virology. It entails several strategies used to develop antiviral therapy, including direct-acting antivirals that target viral proteins, enzymes, or nucleic acids; passive antibodies that neutralize viruses circulating in drug; and drugs that target cellular proteins or processes essential for viral replication.
This report aims to provide a comprehensive presentation of the global market for Antiviral Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Therapy. This report contains market size and forecasts of Antiviral Therapy in global, including the following market information:
Global Antiviral Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Antiviral Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Generic Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antiviral Therapy include AbbVie Inc., Abbott, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Merck & Co., Inc., Gilead Sciences, Inc., GlaxoSmithKline plc and Aurobindo Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Antiviral Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiviral Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Antiviral Therapy Market Segment Percentages, by Type, 2022 (%)
Generic Drugs
Branded Drugs
Global Antiviral Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Antiviral Therapy Market Segment Percentages, by Application, 2022 (%)
HIV
Hepatitis
Herpes
Virus Influenza
Others
Global Antiviral Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Antiviral Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiviral Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antiviral Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc.
Abbott
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Aurobindo Pharma
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiviral Therapy, market overview.
Chapter 2: Global Antiviral Therapy market size in revenue.
Chapter 3: Detailed analysis of Antiviral Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiviral Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antiviral Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antiviral Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiviral Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiviral Therapy Overall Market Size
2.1 Global Antiviral Therapy Market Size: 2022 VS 2030
2.2 Global Antiviral Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiviral Therapy Players in Global Market
3.2 Top Global Antiviral Therapy Companies Ranked by Revenue
3.3 Global Antiviral Therapy Revenue by Companies
3.4 Top 3 and Top 5 Antiviral Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antiviral Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiviral Therapy Players in Global Market
3.6.1 List of Global Tier 1 Antiviral Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiviral Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antiviral Therapy Market Size Markets, 2022 & 2030
4.1.2 Generic Drugs
4.1.3 Branded Drugs
4.2 By Type - Global Antiviral Therapy Revenue & Forecasts
4.2.1 By Type - Global Antiviral Therapy Revenue, 2018-2023
4.2.2 By Type - Global Antiviral Therapy Revenue, 2024-2030
4.2.3 By Type - Global Antiviral Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antiviral Therapy Market Size, 2022 & 2030
5.1.2 HIV
5.1.3 Hepatitis
5.1.4 Herpes
5.1.5 Virus Influenza
5.1.6 Others
5.2 By Application - Global Antiviral Therapy Revenue & Forecasts
5.2.1 By Application - Global Antiviral Therapy Revenue, 2018-2023
5.2.2 By Application - Global Antiviral Therapy Revenue, 2024-2030
5.2.3 By Application - Global Antiviral Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Antiviral Therapy Market Size, 2022 & 2030
6.2 By Region - Global Antiviral Therapy Revenue & Forecasts
6.2.1 By Region - Global Antiviral Therapy Revenue, 2018-2023
6.2.2 By Region - Global Antiviral Therapy Revenue, 2024-2030
6.2.3 By Region - Global Antiviral Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Antiviral Therapy Revenue, 2018-2030
6.3.2 US Antiviral Therapy Market Size, 2018-2030
6.3.3 Canada Antiviral Therapy Market Size, 2018-2030
6.3.4 Mexico Antiviral Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Antiviral Therapy Revenue, 2018-2030
6.4.2 Germany Antiviral Therapy Market Size, 2018-2030
6.4.3 France Antiviral Therapy Market Size, 2018-2030
6.4.4 U.K. Antiviral Therapy Market Size, 2018-2030
6.4.5 Italy Antiviral Therapy Market Size, 2018-2030
6.4.6 Russia Antiviral Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Antiviral Therapy Market Size, 2018-2030
6.4.8 Benelux Antiviral Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Antiviral Therapy Revenue, 2018-2030
6.5.2 China Antiviral Therapy Market Size, 2018-2030
6.5.3 Japan Antiviral Therapy Market Size, 2018-2030
6.5.4 South Korea Antiviral Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Antiviral Therapy Market Size, 2018-2030
6.5.6 India Antiviral Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Antiviral Therapy Revenue, 2018-2030
6.6.2 Brazil Antiviral Therapy Market Size, 2018-2030
6.6.3 Argentina Antiviral Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antiviral Therapy Revenue, 2018-2030
6.7.2 Turkey Antiviral Therapy Market Size, 2018-2030
6.7.3 Israel Antiviral Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Antiviral Therapy Market Size, 2018-2030
6.7.5 UAE Antiviral Therapy Market Size, 2018-2030
7 Antiviral Therapy Companies Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Company Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. Antiviral Therapy Major Product Offerings
7.1.4 AbbVie Inc. Antiviral Therapy Revenue in Global Market (2018-2023)
7.1.5 AbbVie Inc. Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Antiviral Therapy Major Product Offerings
7.2.4 Abbott Antiviral Therapy Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Company Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd Antiviral Therapy Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd Antiviral Therapy Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 Bristol-Myers Squibb Company
7.4.1 Bristol-Myers Squibb Company Company Summary
7.4.2 Bristol-Myers Squibb Company Business Overview
7.4.3 Bristol-Myers Squibb Company Antiviral Therapy Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Antiviral Therapy Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.5 Johnson & Johnson Services, Inc.
7.5.1 Johnson & Johnson Services, Inc. Company Summary
7.5.2 Johnson & Johnson Services, Inc. Business Overview
7.5.3 Johnson & Johnson Services, Inc. Antiviral Therapy Major Product Offerings
7.5.4 Johnson & Johnson Services, Inc. Antiviral Therapy Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Services, Inc. Key News & Latest Developments
7.6 Merck & Co., Inc.
7.6.1 Merck & Co., Inc. Company Summary
7.6.2 Merck & Co., Inc. Business Overview
7.6.3 Merck & Co., Inc. Antiviral Therapy Major Product Offerings
7.6.4 Merck & Co., Inc. Antiviral Therapy Revenue in Global Market (2018-2023)
7.6.5 Merck & Co., Inc. Key News & Latest Developments
7.7 Gilead Sciences, Inc.
7.7.1 Gilead Sciences, Inc. Company Summary
7.7.2 Gilead Sciences, Inc. Business Overview
7.7.3 Gilead Sciences, Inc. Antiviral Therapy Major Product Offerings
7.7.4 Gilead Sciences, Inc. Antiviral Therapy Revenue in Global Market (2018-2023)
7.7.5 Gilead Sciences, Inc. Key News & Latest Developments
7.8 GlaxoSmithKline plc
7.8.1 GlaxoSmithKline plc Company Summary
7.8.2 GlaxoSmithKline plc Business Overview
7.8.3 GlaxoSmithKline plc Antiviral Therapy Major Product Offerings
7.8.4 GlaxoSmithKline plc Antiviral Therapy Revenue in Global Market (2018-2023)
7.8.5 GlaxoSmithKline plc Key News & Latest Developments
7.9 Aurobindo Pharma
7.9.1 Aurobindo Pharma Company Summary
7.9.2 Aurobindo Pharma Business Overview
7.9.3 Aurobindo Pharma Antiviral Therapy Major Product Offerings
7.9.4 Aurobindo Pharma Antiviral Therapy Revenue in Global Market (2018-2023)
7.9.5 Aurobindo Pharma Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Company Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Antiviral Therapy Major Product Offerings
7.10.4 AstraZeneca Antiviral Therapy Revenue in Global Market (2018-2023)
7.10.5 AstraZeneca Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antiviral Therapy Market Opportunities & Trends in Global Market
Table 2. Antiviral Therapy Market Drivers in Global Market
Table 3. Antiviral Therapy Market Restraints in Global Market
Table 4. Key Players of Antiviral Therapy in Global Market
Table 5. Top Antiviral Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antiviral Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antiviral Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antiviral Therapy Product Type
Table 9. List of Global Tier 1 Antiviral Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiviral Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Antiviral Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Antiviral Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antiviral Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Antiviral Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Antiviral Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antiviral Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Antiviral Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Antiviral Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antiviral Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Antiviral Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antiviral Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Antiviral Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antiviral Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Antiviral Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antiviral Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Antiviral Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antiviral Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Antiviral Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antiviral Therapy Revenue, (US$, Mn), 2024-2030
Table 30. AbbVie Inc. Company Summary
Table 31. AbbVie Inc. Antiviral Therapy Product Offerings
Table 32. AbbVie Inc. Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Inc. Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Antiviral Therapy Product Offerings
Table 36. Abbott Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Ltd Company Summary
Table 39. F. Hoffmann-La Roche Ltd Antiviral Therapy Product Offerings
Table 40. F. Hoffmann-La Roche Ltd Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Company Summary
Table 43. Bristol-Myers Squibb Company Antiviral Therapy Product Offerings
Table 44. Bristol-Myers Squibb Company Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Company Key News & Latest Developments
Table 46. Johnson & Johnson Services, Inc. Company Summary
Table 47. Johnson & Johnson Services, Inc. Antiviral Therapy Product Offerings
Table 48. Johnson & Johnson Services, Inc. Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Services, Inc. Key News & Latest Developments
Table 50. Merck & Co., Inc. Company Summary
Table 51. Merck & Co., Inc. Antiviral Therapy Product Offerings
Table 52. Merck & Co., Inc. Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Merck & Co., Inc. Key News & Latest Developments
Table 54. Gilead Sciences, Inc. Company Summary
Table 55. Gilead Sciences, Inc. Antiviral Therapy Product Offerings
Table 56. Gilead Sciences, Inc. Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Gilead Sciences, Inc. Key News & Latest Developments
Table 58. GlaxoSmithKline plc Company Summary
Table 59. GlaxoSmithKline plc Antiviral Therapy Product Offerings
Table 60. GlaxoSmithKline plc Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. GlaxoSmithKline plc Key News & Latest Developments
Table 62. Aurobindo Pharma Company Summary
Table 63. Aurobindo Pharma Antiviral Therapy Product Offerings
Table 64. Aurobindo Pharma Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Aurobindo Pharma Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca Antiviral Therapy Product Offerings
Table 68. AstraZeneca Antiviral Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. AstraZeneca Key News & Latest Developments
List of Figures
Figure 1. Antiviral Therapy Segment by Type in 2022
Figure 2. Antiviral Therapy Segment by Application in 2022
Figure 3. Global Antiviral Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antiviral Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Antiviral Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiviral Therapy Revenue in 2022
Figure 8. By Type - Global Antiviral Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Antiviral Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Antiviral Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Antiviral Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Antiviral Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Antiviral Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Antiviral Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Antiviral Therapy Revenue Market Share, 2018-2030
Figure 16. US Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Antiviral Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Antiviral Therapy Revenue Market Share, 2018-2030
Figure 28. China Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Antiviral Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Antiviral Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Antiviral Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. AbbVie Inc. Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffmann-La Roche Ltd Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Company Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Services, Inc. Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck & Co., Inc. Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Gilead Sciences, Inc. Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GlaxoSmithKline plc Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Aurobindo Pharma Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AstraZeneca Antiviral Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
